Uncompromising CapabilityMDS Nordion’s specialized knowledge in radiopharmaceutical development and manufacturing helps biotechnology and pharmaceutical companies bring new drugs from concept to market reality. We’ve proven our leadership through groundbreaking partnerships. Working with Macrocyclics Inc., a leading provider of chelates and linkers, MDS Nordion is focusing on developing novel chelate structures, linkers and conjugation methods. By providing the research community with a wider range of targeting vectors, new areas of investigation in targeted therapy can be explored. We can help at each step of the drug discovery and development process.
Learn more about how we can tailor our radiopharmaceutical services to your targeting molecule. To contact us click here. |
